arrow
E

Edward D. Esplin

Stanford School of Medicine
H指数:36
被引数:6,957

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis

作者更正:多组学分析家族性腺瘤性息肉病揭示与早期肿瘤发生相关的分子通路

2026-10-220
OAAI
The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments

电子病历与基因组学研究:评估基因组信息风险评估影响的设计与分析框架

2026-03-230
OAAI
Polyclonal origins of human premalignant colorectal lesions

人类癌前结直肠病变的多克隆起源

Nature
IF48.5
2025-11-250
PRE
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients

利用PROCLAIM试验中的患者报告结局评估对前列腺癌患者进行普遍胚系基因检测的影响

2025-09-220
OAAI
Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility

骨与软组织肉瘤患者中的生殖细胞系遗传学检测:一项评估癌症易感性的前瞻性多中心研究

2025-03-210
OA
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer

针对前列腺癌患者进行通用种系基因检测的临床报告管理建议

2024-12-013
PRE
Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis

家族性腺瘤性息肉病的多组学分析揭示了与早期肿瘤发生相关的分子途径

2024-10-301
OAAI
Global loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesis

早期结直肠癌癌变过程中启动子-增强子连接的整体缺失和基因表达的再平衡

2024-10-302
OAAI
Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network

管理跨组多基因风险评分的差异表现: eMERGE网络的现实经验

2024-06-013
PRE
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study
2024-06-011
PRE